Concepedia
Statistics
Publications
16
Citations
1.4K
H-Index
14
Active since
2012
Affiliations
Medical University of Graz(Current)
Paracelsus Medical University
The University of Texas MD Anderson Cancer Center
Salzburger Landeskliniken
Graz University of Technology
Anna Lena Ress is an author at Medical University of Graz specializing in oncology, medicine, and molecular oncology.
Publications per year
2012–2017
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
Michael Stotz, Armin Gerger, Florian Eisner et al. · British Journal of Cancer · 2013 · 498 citations · Full text
Medicine, Hematology, Oncology +17
Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
Joanna Szkandera, Michael Stotz, Gudrun Absenger et al. · British Journal of Cancer · 2013 · 194 citations · Full text
Medicine, Immunology, Oncology +17
MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients
Martin Pichler, Anna Lena Ress, Elke Winter et al. · British Journal of Cancer · 2014 · 112 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients
Joanna Szkandera, Michael Stotz, Florian Eisner et al. · PLoS ONE · 2013 · 97 citations · Full text
Medicine, Cancer Biology, Oncology +17
miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor
Martin Pichler, Elke Winter, Anna Lena Ress et al. · Journal of Clinical Pathology · 2013 · 95 citations
Medicine, Oncology, Pharmacology +17
1–5 of 16